Nedaplatin reduces multidrug resistance of non-small cell lung cancer by downregulating the expression of long non-coding RNA MVIH

Cisplatin-based chemotherapy is the standard treatment for non-small cell lung cancer (NSCLC). However, drug resistance emergences after treatment. Long non-coding RNA microvascular invasion in hepatic cancer (MVIH) plays an important role in drug resistance in a variety of cancers. This study inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Changwen, Wang, Zhuo, Lou, Rui, Wu, Jianzhong, Shi, Chen, Chen, Dan, Ma, Rong, Liu, Siwen, Cao, Haixia, Feng, Jifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959054/
https://www.ncbi.nlm.nih.gov/pubmed/31942179
http://dx.doi.org/10.7150/jca.35792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959054/
https://www.ncbi.nlm.nih.gov/pubmed/31942179
http://dx.doi.org/10.7150/jca.35792

Ejemplares similares